ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Neos Therapeutics, Inc.
1.15
0.0000
成交量:
- -
成交額:
- -
市值:
5,722.02萬
市盈率:
-2.62
高:
1.15
開:
1.15
低:
1.15
收:
1.15
52周最高:
1.68
52周最低:
0.4501
股本:
4,975.67萬
流通股本:
4,023.17萬
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-0.4394
每股收益(LYR):
-0.3399
淨資產收益率:
185.39%
總資產收益率:
-10.71%
市淨率:
-2.78
市盈率(LYR):
-3.38
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字:
Neos Therapeutics, Inc.
交易所:
NASDAQ
成立時間:
- -
員工人數:
- -
公司地址:
- -
官網:
http://www.neostx.com
郵編:
- -
電話:
- -
傳真:
- -
簡介:
Neos治療公司,是一家成立於特拉華州的完全綜合性製藥企業。該公司已開發出全面的,專有的調節釋放藥物輸送技術用於單個和多個成分緩釋型藥物在患者和照料者的口腔崩解片和液體懸浮液劑型的生產。該公司的前身公司PharmaFab, Inc.於1994年11月30日在得克薩斯州註冊成立,隨後更名為Neostx, Inc.。於2009年6月15日完成了重組,耗費近乎所有資本存量收購了一家新成立的特拉華州的公司,命名為Neos治療公司。公司主要從事開發及生產未經批準的、程度較輕的藥品及保健食品。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NEOS/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NEOS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NEOS\",,,,,undefined,":{"symbol":"NEOS","market":"US","secType":"STK","nameCN":"Neos Therapeutics, Inc.","latestPrice":1.15,"timestamp":1616184000000,"preClose":1.15,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":40231679,"shares":49756656,"eps":-0.439394,"marketStatus":"退市","change":0,"latestTime":"03-19 16:00:00 EDT","open":1.15,"high":1.15,"low":1.15,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.439394,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1772010000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1437624000000,"exchange":"NASDAQ","adjPreClose":1.15,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NEOS\",,,,,undefined,":{"symbol":"NEOS","floatShares":40231679,"roa":"-10.71%","roe":"185.39%","lyrEps":-0.339917,"shares":49756656,"dividePrice":0,"high":1.15,"amplitude":0,"preClose":1.15,"low":1.15,"week52Low":0.4501,"pbRate":"-2.78","week52High":1.68,"institutionHeld":0,"latestPrice":1.15,"eps":-0.439394,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.439394,"open":1.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NEOS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-03-22","symbol":"NEOS","reason":null,"defaultRemindTime":1616419800000,"announcedDate":"2021-03-17","type":"delisting","dateTimestamp":1616385600000},{"market":"US","date":"2021-03-19","symbol":"NEOS","fiscalQuarterEnding":"2020/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1616126400000,"reportTimeType":"","actualEps":-0.07},{"date":"2020-11-09","symbol":"NEOS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2020/09","expectedEps":-0.05,"defaultRemindTime":1604912400000,"name":null,"time":"盤前","dateTimestamp":1604898000000,"actualEps":null},{"date":"2020-08-10","symbol":"NEOS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2020/06","expectedEps":-0.13,"defaultRemindTime":1597046400000,"name":null,"time":"盤前","dateTimestamp":1597032000000,"actualEps":null},{"market":"US","date":"2020-05-11","symbol":"NEOS","fiscalQuarterEnding":"2020/03","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1589169600000,"reportTimeType":"post","actualEps":-0.16}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NEOS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NEOS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NEOS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NEOS","date":"2021-03-19","current":-2.617241,"percent":0.43715,"low":-9.46756,"twenty":-4.838052,"median":-2.209229,"eighty":-1.453292,"high":-0.923609,"avg":-3.098436,"sd":1.892421,"marketCap":58712854},"quantilePoints":[{"date":"2021-02-26","current":-2.048817,"twenty":-4.838052,"median":-2.212267,"eighty":-1.447109,"marketCap":44780990},{"date":"2021-03-05","current":-1.749007,"twenty":-4.838052,"median":-2.209429,"eighty":-1.4531,"marketCap":38228038},{"date":"2021-03-12","current":-2.094118,"twenty":-4.838052,"median":-2.209229,"eighty":-1.453148,"marketCap":45771147},{"date":"2021-03-19","current":-2.686227,"twenty":-4.838052,"median":-2.209229,"eighty":-1.453292,"marketCap":58712854}],"updateTime":1772008550891},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.neostx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":-0.0027},{"period":"3month","weight":0.0113},{"period":"6month","weight":0.0592},{"period":"1year","weight":0.1509},{"period":"ytd","weight":0.008}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Neos治療公司,是一家成立於特拉華州的完全綜合性製藥企業。該公司已開發出全面的,專有的調節釋放藥物輸送技術用於單個和多個成分緩釋型藥物在患者和照料者的口腔崩解片和液體懸浮液劑型的生產。該公司的前身公司PharmaFab, Inc.於1994年11月30日在得克薩斯州註冊成立,隨後更名為Neostx, Inc.。於2009年6月15日完成了重組,耗費近乎所有資本存量收購了一家新成立的特拉華州的公司,命名為Neos治療公司。公司主要從事開發及生產未經批準的、程度較輕的藥品及保健食品。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.097682},{"month":2,"riseRate":0.5,"avgChangeRate":-0.055085},{"month":3,"riseRate":0.666667,"avgChangeRate":0.044193},{"month":4,"riseRate":0.2,"avgChangeRate":-0.029851},{"month":5,"riseRate":0.4,"avgChangeRate":-0.078997},{"month":6,"riseRate":0,"avgChangeRate":-0.090474},{"month":7,"riseRate":0,"avgChangeRate":-0.067149},{"month":8,"riseRate":0.833333,"avgChangeRate":0.160485},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.119751},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.061763},{"month":11,"riseRate":0.5,"avgChangeRate":-0.021534},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.067711}],"exchange":"NASDAQ","name":"Neos Therapeutics, Inc.","nameEN":"Neos Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NEOS\",market:\"US\",,,undefined,":null}}